학술논문


EBSCO Discovery Service
발행년
-
(예 : 2010-2015)
전자자료 공정이용 안내

우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.

공정이용 지침
  • 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
  • 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
  • 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
  • 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
  • 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
  • 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
  • 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
  • 상업적·영리적 목적으로 자료를 전송·복제·활용
  • ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
  • EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
  • 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
  • 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
  • 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문' 에서 검색결과 31건 | 목록 1~20
Academic Journal
Cebekhulu SN; Department of Obstetrics and Gynaecology, Department of Health, Bloemfontein, Bongani Regional Hospital, University of the Free State, Hartbeespoort, South Africa.; Abdul H; Department of Obstetrics & Gynaecology, Queen Nandi Regional Hospital, Empangeni, University of KwaZulu-Natal, KwaZulu-Natal, South Africa.; Batting J; Effective Care Research Unit, Eastern Cape Department of Health, Universities of the Witwatersrand, Walter Sisulu, and Fort Hare, East London, South Africa.; Chauke L; Department of Obstetrics and Gynaecology, Charlotte Maxeke Johannesburg Academic Hospital, University of the Witwatersrand, Witwatersrand, South Africa.; Dlakavu F; Department of Obstetrics and Gynaecology, Steve Biko Academic Hospital, University of Pretoria, Pretoria, South Africa.; Fawcus S; Department Obstetrics and Gynaecology, University of Cape Town, Cape Town, South Africa.; Govender L; Department of Obstetrics & Gynaecology, Queen Nandi Regional Hospital, Empangeni, University of KwaZulu-Natal, KwaZulu-Natal, South Africa.; Majeke B; Department of Obstetrics and Gynaecology at Cecilia Makiwane Hospital, Walter Sisulu University, East London, South Africa.; Mbongozi X; Department of Obstetrics and Gynaecology, Nelson Mandela Academic Hospital, Walter Sisulu University, Mthatha, South Africa.; Singata-Madliki M; Effective Care Research Unit, Eastern Cape Department of Health, Universities of the Witwatersrand, Walter Sisulu, and Fort Hare, East London, South Africa.; Middleton K; Department of Obstetrics and Gynaecology, Frere Hospital and Walter Sisulu University, East London, South Africa.; Mlandu P; Department of Obstetrics and Gynaecology, Chris Hani Baragwaneth Academic Hospital, University of the Witwatersrand, Johannesburg, South Africa.; Naidoo P; Department of Obstetrics and Gynaecology, Chris Hani Baragwaneth Academic Hospital, University of the Witwatersrand, Johannesburg, South Africa.; Ndaba S; Department of Obstetrics and Gynaecology Kalafong Hospital, University of Pretoria, Pretoria, South Africa.; Soma-Pillay P; UP/SAMRC Research Centre for Maternal, Fetal, Newborn and Child Healthcare Strategies, Department of Obstetrics and Gynaecology Steve Biko Academic Hospital, University of Pretoria, Pretoria, South Africa.; Spence T; Department of Obstetrics and Gynaecology, New Somerset Hospital, Cape Town, South Africa.; Ntambua SC; Department of Health, Department of Obstetrics and Gynaecology, Bongani Regional Hospital, Free State, Hartbeespoort, South Africa.; Hofmeyr J; Effective Care Research Unit, Eastern Cape Department of Health, Universities of the Witwatersrand, Walter Sisulu, and Fort Hare, East London, South Africa.; University of Botswana, Botswana, South Africa.
Publisher: Wiley Country of Publication: United States NLM ID: 0210174 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-3479 (Electronic) Linking ISSN: 00207292 NLM ISO Abbreviation: Int J Gynaecol Obstet Subsets: MEDLINE
Book
In: The Palgrave Handbook on China-Europe-Africa Relations. (The Palgrave Handbook on China-Europe-Africa Relations, 9 January 2025, :661-678)
Academic Journal
Rozot, V.Nemes, E.Geldenhuys, H.Musvosvi, M.Toefy, A.Rantangee, F.Makhethe, L.Erasmus, M.Bilek, N.Mabwe, S.Hatherill, M.Scriba, T.J.Abrahams, C.Africa, H.Alexander, F.Amsterdam, J.Arendsen, D.Beyers, E.Botes, N.Botes, J.Braaf, S.Cloete, Y.Companie, A.Davids, I.Diamond, B.Dlakavu, P.Dolo, P.Elbring, C.Erasmus, M.Esterhuizen, T.Gempies, D.Goliath, S.Gregg, Y.Hamilton, E.Hanekom, W.A.Hector, J.Herling, R.Herselman, Y.Hughes, J.Issel, H.Jaxa, L.Jones, C.Kassiem, J.Keffers, S.Kelepu, X.Keyser, A.Kruger, S.Langata, P.Luabeya, A.Mactavie, L.Makunzi, L.Mangala, P.Maqubela, C.Mosito, B.Mouton, A.Mulenga, H.Mullins, M.Noble, J.Nombida, O.Ockhuis, R.Opperman, F.Petersen, C.Pretorius, A.Pretorius, D.Raphela, R.Ratangee, M.Rossouw, S.Schoeman, E.Schreuder, C.September, C.Shenje, J.Sinandile, E.Steyn, M.Swarts, A.Tameris, M.Tyambetyu, P.van der Riet, E.van der Westhuizen, D.van Rooyen, E.Veldsman, A.Veltdsman, H.Vermeulen, E.Matiwane, S.W.Xoyana, N.Finak, G.Fulp, W.Ginsberg, A.M.Hokey, D.A.Aderiye, M.Dubel, S.Ellis, R.D.Evans, T.Fattore, C.Hopkins, R.Hunt, D.Landry, B.Lempicki, M.O’Dee, D.Raine, M.Rutkowski, K.T.Shepherd, B.Siefers, H.Sutton, S.Shey, M.Kromann, I.Omarjee, S.Gurunathan, S.DiazGranados, C.Brooks, R.de Bruyn, G.Gomes, P.Janosczyk, H.Kieffer, A.Locas, M.-C.O’Neil, A.Patel, D.Rauner, C.Ryall, R.Syntin, P.Bekker, L.-G.Roux, S.van der Vendt, D.Albertyn, D.Bester, H.Croucher, K.Gelderbloem, S.Lambrick, M.van der Merwe, A.van der Westhuizen, A.Andersen, P.Skea, D.Su, J.Self, S.G.
In: Communications Biology. (Communications Biology, 1 December 2020, 3(1))
Academic Journal
In: African Evaluation Journal. (African Evaluation Journal, 2020, 38:1-9)
Book
In: Handbook of Public Policy Evaluation. (Handbook of Public Policy Evaluation, 19 October 2023, :317-336)
Book
In: Xenophobia and Nativism in Africa, Latin America, and the Caribbean. (Xenophobia and Nativism in Africa, Latin America, and the Caribbean, 1 January 2023, :15-33)
Academic Journal
In: Agenda. (Agenda, 2017, 31(3-4):105-109)
Academic Journal
Elisa NemesVirginie RozotHennie GeldenhuysNicole BilekSimbarashe MabweDeborah AbrahamsLebohang MakhetheMzwandile ErasmusAlana KeyserAsma ToefyYolundi CloeteFrances RatangeeThomas BlauenfeldtMorten RuhwaldGerhard WalzlBronwyn SmithAndre G. LoxtonWillem A. HanekomJason R. AndrewsMaria D. LempickiRuth EllisAnn M. GinsbergMark HatherillThomas J. ScribaSusan RossouwCarolyn JonesElisma SchoemanYolande GreggElizabeth BeyersSandra KrugerHelen VeltdsmanSophie KeffersSandra GoliathMariana MullinsMichele TamerisAngelique LuabeyaAshley VeldsmanHumphrey MulengaAngelique HendricksFajwa OppermanElma Van RooyenJulia NobleSamentra BraafRose OckhuisEmerencia VermeulenAlessandro CompanieXoliswa KelepuMaigan RatangeeAbraham PretoriusHenry IsselPhumzile LangataIlse DavidsRoxanne HerlingHadn AfricaMarcia SteynLungisa NkantsoNoncedo XoyanaBongani DiamondMargareth ErasmusJane HughesDenise van der WesthuizenLydia MakunziNatasja BotesJulia AmsterdamClive MaqubelaPortia DlakavuPamela MangalaCharmaine AbrahamsPetrus TyambetyuDiann GempiesCindy ElbringElizabeth HamiltonFadia AlexanderSindile Wiseman MatiwaneCashwin SeptemberChristel PetersenYulande HerselmanJohanna HectorTerence EsterhuizenLauren MactavieElize van der RietDebbie PretoriusJustin ShenjeAnne SwartsEunice SinandileJanelle BotesConstance SchreuderJateel KassiemOnke XasaBoitumelo MositoRodney RaphelaDenis ArendsenPalesa DoloElizabeth FilanderHassan MahomedFazlin KafaarLeslie WorkmanRodney EhrlichSizulu MoyoSebastian GelderbloemGregory Hussey
American Journal of Respiratory and Critical Care Medicine. 196:638-648
Academic Journal
Nemes E; From the South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, Department of Pathology (E.N., H.G., V.R., F.R., N.B., S.M., L.M., M.E., A.T., H.M., W.A.H., T.J.S., M.H.), and Desmond Tutu HIV Foundation (L.-G.B.), University of Cape Town, Cape Town, South Africa; Aeras, Rockville, MD (K.T.R., T.E., R.D.E., B.L., D.A.H., R.H., A.M.G.); Statistical Center for HIV Research, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle (S.G.S.); Sanofi Pasteur, Swiftwater, PA (R.R., S.G., C.A.D.); and Center for Vaccine Research, Statens Serum Institut, Copenhagen (P.A., I.K.).; Geldenhuys H; From the South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, Department of Pathology (E.N., H.G., V.R., F.R., N.B., S.M., L.M., M.E., A.T., H.M., W.A.H., T.J.S., M.H.), and Desmond Tutu HIV Foundation (L.-G.B.), University of Cape Town, Cape Town, South Africa; Aeras, Rockville, MD (K.T.R., T.E., R.D.E., B.L., D.A.H., R.H., A.M.G.); Statistical Center for HIV Research, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle (S.G.S.); Sanofi Pasteur, Swiftwater, PA (R.R., S.G., C.A.D.); and Center for Vaccine Research, Statens Serum Institut, Copenhagen (P.A., I.K.).; Rozot V; From the South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, Department of Pathology (E.N., H.G., V.R., F.R., N.B., S.M., L.M., M.E., A.T., H.M., W.A.H., T.J.S., M.H.), and Desmond Tutu HIV Foundation (L.-G.B.), University of Cape Town, Cape Town, South Africa; Aeras, Rockville, MD (K.T.R., T.E., R.D.E., B.L., D.A.H., R.H., A.M.G.); Statistical Center for HIV Research, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle (S.G.S.); Sanofi Pasteur, Swiftwater, PA (R.R., S.G., C.A.D.); and Center for Vaccine Research, Statens Serum Institut, Copenhagen (P.A., I.K.).; Rutkowski KT; From the South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, Department of Pathology (E.N., H.G., V.R., F.R., N.B., S.M., L.M., M.E., A.T., H.M., W.A.H., T.J.S., M.H.), and Desmond Tutu HIV Foundation (L.-G.B.), University of Cape Town, Cape Town, South Africa; Aeras, Rockville, MD (K.T.R., T.E., R.D.E., B.L., D.A.H., R.H., A.M.G.); Statistical Center for HIV Research, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle (S.G.S.); Sanofi Pasteur, Swiftwater, PA (R.R., S.G., C.A.D.); and Center for Vaccine Research, Statens Serum Institut, Copenhagen (P.A., I.K.).; Ratangee F; From the South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, Department of Pathology (E.N., H.G., V.R., F.R., N.B., S.M., L.M., M.E., A.T., H.M., W.A.H., T.J.S., M.H.), and Desmond Tutu HIV Foundation (L.-G.B.), University of Cape Town, Cape Town, South Africa; Aeras, Rockville, MD (K.T.R., T.E., R.D.E., B.L., D.A.H., R.H., A.M.G.); Statistical Center for HIV Research, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle (S.G.S.); Sanofi Pasteur, Swiftwater, PA (R.R., S.G., C.A.D.); and Center for Vaccine Research, Statens Serum Institut, Copenhagen (P.A., I.K.).; Bilek N; From the South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, Department of Pathology (E.N., H.G., V.R., F.R., N.B., S.M., L.M., M.E., A.T., H.M., W.A.H., T.J.S., M.H.), and Desmond Tutu HIV Foundation (L.-G.B.), University of Cape Town, Cape Town, South Africa; Aeras, Rockville, MD (K.T.R., T.E., R.D.E., B.L., D.A.H., R.H., A.M.G.); Statistical Center for HIV Research, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle (S.G.S.); Sanofi Pasteur, Swiftwater, PA (R.R., S.G., C.A.D.); and Center for Vaccine Research, Statens Serum Institut, Copenhagen (P.A., I.K.).; Mabwe S; From the South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, Department of Pathology (E.N., H.G., V.R., F.R., N.B., S.M., L.M., M.E., A.T., H.M., W.A.H., T.J.S., M.H.), and Desmond Tutu HIV Foundation (L.-G.B.), University of Cape Town, Cape Town, South Africa; Aeras, Rockville, MD (K.T.R., T.E., R.D.E., B.L., D.A.H., R.H., A.M.G.); Statistical Center for HIV Research, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle (S.G.S.); Sanofi Pasteur, Swiftwater, PA (R.R., S.G., C.A.D.); and Center for Vaccine Research, Statens Serum Institut, Copenhagen (P.A., I.K.).; Makhethe L; From the South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, Department of Pathology (E.N., H.G., V.R., F.R., N.B., S.M., L.M., M.E., A.T., H.M., W.A.H., T.J.S., M.H.), and Desmond Tutu HIV Foundation (L.-G.B.), University of Cape Town, Cape Town, South Africa; Aeras, Rockville, MD (K.T.R., T.E., R.D.E., B.L., D.A.H., R.H., A.M.G.); Statistical Center for HIV Research, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle (S.G.S.); Sanofi Pasteur, Swiftwater, PA (R.R., S.G., C.A.D.); and Center for Vaccine Research, Statens Serum Institut, Copenhagen (P.A., I.K.).; Erasmus M; From the South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, Department of Pathology (E.N., H.G., V.R., F.R., N.B., S.M., L.M., M.E., A.T., H.M., W.A.H., T.J.S., M.H.), and Desmond Tutu HIV Foundation (L.-G.B.), University of Cape Town, Cape Town, South Africa; Aeras, Rockville, MD (K.T.R., T.E., R.D.E., B.L., D.A.H., R.H., A.M.G.); Statistical Center for HIV Research, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle (S.G.S.); Sanofi Pasteur, Swiftwater, PA (R.R., S.G., C.A.D.); and Center for Vaccine Research, Statens Serum Institut, Copenhagen (P.A., I.K.).; Toefy A; From the South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, Department of Pathology (E.N., H.G., V.R., F.R., N.B., S.M., L.M., M.E., A.T., H.M., W.A.H., T.J.S., M.H.), and Desmond Tutu HIV Foundation (L.-G.B.), University of Cape Town, Cape Town, South Africa; Aeras, Rockville, MD (K.T.R., T.E., R.D.E., B.L., D.A.H., R.H., A.M.G.); Statistical Center for HIV Research, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle (S.G.S.); Sanofi Pasteur, Swiftwater, PA (R.R., S.G., C.A.D.); and Center for Vaccine Research, Statens Serum Institut, Copenhagen (P.A., I.K.).; Mulenga H; From the South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, Department of Pathology (E.N., H.G., V.R., F.R., N.B., S.M., L.M., M.E., A.T., H.M., W.A.H., T.J.S., M.H.), and Desmond Tutu HIV Foundation (L.-G.B.), University of Cape Town, Cape Town, South Africa; Aeras, Rockville, MD (K.T.R., T.E., R.D.E., B.L., D.A.H., R.H., A.M.G.); Statistical Center for HIV Research, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle (S.G.S.); Sanofi Pasteur, Swiftwater, PA (R.R., S.G., C.A.D.); and Center for Vaccine Research, Statens Serum Institut, Copenhagen (P.A., I.K.).; Hanekom WA; From the South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, Department of Pathology (E.N., H.G., V.R., F.R., N.B., S.M., L.M., M.E., A.T., H.M., W.A.H., T.J.S., M.H.), and Desmond Tutu HIV Foundation (L.-G.B.), University of Cape Town, Cape Town, South Africa; Aeras, Rockville, MD (K.T.R., T.E., R.D.E., B.L., D.A.H., R.H., A.M.G.); Statistical Center for HIV Research, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle (S.G.S.); Sanofi Pasteur, Swiftwater, PA (R.R., S.G., C.A.D.); and Center for Vaccine Research, Statens Serum Institut, Copenhagen (P.A., I.K.).; Self SG; From the South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, Department of Pathology (E.N., H.G., V.R., F.R., N.B., S.M., L.M., M.E., A.T., H.M., W.A.H., T.J.S., M.H.), and Desmond Tutu HIV Foundation (L.-G.B.), University of Cape Town, Cape Town, South Africa; Aeras, Rockville, MD (K.T.R., T.E., R.D.E., B.L., D.A.H., R.H., A.M.G.); Statistical Center for HIV Research, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle (S.G.S.); Sanofi Pasteur, Swiftwater, PA (R.R., S.G., C.A.D.); and Center for Vaccine Research, Statens Serum Institut, Copenhagen (P.A., I.K.).; Bekker LG; From the South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, Department of Pathology (E.N., H.G., V.R., F.R., N.B., S.M., L.M., M.E., A.T., H.M., W.A.H., T.J.S., M.H.), and Desmond Tutu HIV Foundation (L.-G.B.), University of Cape Town, Cape Town, South Africa; Aeras, Rockville, MD (K.T.R., T.E., R.D.E., B.L., D.A.H., R.H., A.M.G.); Statistical Center for HIV Research, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle (S.G.S.); Sanofi Pasteur, Swiftwater, PA (R.R., S.G., C.A.D.); and Center for Vaccine Research, Statens Serum Institut, Copenhagen (P.A., I.K.).; Ryall R; From the South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, Department of Pathology (E.N., H.G., V.R., F.R., N.B., S.M., L.M., M.E., A.T., H.M., W.A.H., T.J.S., M.H.), and Desmond Tutu HIV Foundation (L.-G.B.), University of Cape Town, Cape Town, South Africa; Aeras, Rockville, MD (K.T.R., T.E., R.D.E., B.L., D.A.H., R.H., A.M.G.); Statistical Center for HIV Research, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle (S.G.S.); Sanofi Pasteur, Swiftwater, PA (R.R., S.G., C.A.D.); and Center for Vaccine Research, Statens Serum Institut, Copenhagen (P.A., I.K.).; Gurunathan S; From the South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, Department of Pathology (E.N., H.G., V.R., F.R., N.B., S.M., L.M., M.E., A.T., H.M., W.A.H., T.J.S., M.H.), and Desmond Tutu HIV Foundation (L.-G.B.), University of Cape Town, Cape Town, South Africa; Aeras, Rockville, MD (K.T.R., T.E., R.D.E., B.L., D.A.H., R.H., A.M.G.); Statistical Center for HIV Research, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle (S.G.S.); Sanofi Pasteur, Swiftwater, PA (R.R., S.G., C.A.D.); and Center for Vaccine Research, Statens Serum Institut, Copenhagen (P.A., I.K.).; DiazGranados CA; From the South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, Department of Pathology (E.N., H.G., V.R., F.R., N.B., S.M., L.M., M.E., A.T., H.M., W.A.H., T.J.S., M.H.), and Desmond Tutu HIV Foundation (L.-G.B.), University of Cape Town, Cape Town, South Africa; Aeras, Rockville, MD (K.T.R., T.E., R.D.E., B.L., D.A.H., R.H., A.M.G.); Statistical Center for HIV Research, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle (S.G.S.); Sanofi Pasteur, Swiftwater, PA (R.R., S.G., C.A.D.); and Center for Vaccine Research, Statens Serum Institut, Copenhagen (P.A., I.K.).; Andersen P; From the South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, Department of Pathology (E.N., H.G., V.R., F.R., N.B., S.M., L.M., M.E., A.T., H.M., W.A.H., T.J.S., M.H.), and Desmond Tutu HIV Foundation (L.-G.B.), University of Cape Town, Cape Town, South Africa; Aeras, Rockville, MD (K.T.R., T.E., R.D.E., B.L., D.A.H., R.H., A.M.G.); Statistical Center for HIV Research, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle (S.G.S.); Sanofi Pasteur, Swiftwater, PA (R.R., S.G., C.A.D.); and Center for Vaccine Research, Statens Serum Institut, Copenhagen (P.A., I.K.).; Kromann I; From the South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, Department of Pathology (E.N., H.G., V.R., F.R., N.B., S.M., L.M., M.E., A.T., H.M., W.A.H., T.J.S., M.H.), and Desmond Tutu HIV Foundation (L.-G.B.), University of Cape Town, Cape Town, South Africa; Aeras, Rockville, MD (K.T.R., T.E., R.D.E., B.L., D.A.H., R.H., A.M.G.); Statistical Center for HIV Research, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle (S.G.S.); Sanofi Pasteur, Swiftwater, PA (R.R., S.G., C.A.D.); and Center for Vaccine Research, Statens Serum Institut, Copenhagen (P.A., I.K.).; Evans T; From the South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, Department of Pathology (E.N., H.G., V.R., F.R., N.B., S.M., L.M., M.E., A.T., H.M., W.A.H., T.J.S., M.H.), and Desmond Tutu HIV Foundation (L.-G.B.), University of Cape Town, Cape Town, South Africa; Aeras, Rockville, MD (K.T.R., T.E., R.D.E., B.L., D.A.H., R.H., A.M.G.); Statistical Center for HIV Research, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle (S.G.S.); Sanofi Pasteur, Swiftwater, PA (R.R., S.G., C.A.D.); and Center for Vaccine Research, Statens Serum Institut, Copenhagen (P.A., I.K.).; Ellis RD; From the South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, Department of Pathology (E.N., H.G., V.R., F.R., N.B., S.M., L.M., M.E., A.T., H.M., W.A.H., T.J.S., M.H.), and Desmond Tutu HIV Foundation (L.-G.B.), University of Cape Town, Cape Town, South Africa; Aeras, Rockville, MD (K.T.R., T.E., R.D.E., B.L., D.A.H., R.H., A.M.G.); Statistical Center for HIV Research, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle (S.G.S.); Sanofi Pasteur, Swiftwater, PA (R.R., S.G., C.A.D.); and Center for Vaccine Research, Statens Serum Institut, Copenhagen (P.A., I.K.).; Landry B; From the South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, Department of Pathology (E.N., H.G., V.R., F.R., N.B., S.M., L.M., M.E., A.T., H.M., W.A.H., T.J.S., M.H.), and Desmond Tutu HIV Foundation (L.-G.B.), University of Cape Town, Cape Town, South Africa; Aeras, Rockville, MD (K.T.R., T.E., R.D.E., B.L., D.A.H., R.H., A.M.G.); Statistical Center for HIV Research, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle (S.G.S.); Sanofi Pasteur, Swiftwater, PA (R.R., S.G., C.A.D.); and Center for Vaccine Research, Statens Serum Institut, Copenhagen (P.A., I.K.).; Hokey DA; From the South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, Department of Pathology (E.N., H.G., V.R., F.R., N.B., S.M., L.M., M.E., A.T., H.M., W.A.H., T.J.S., M.H.), and Desmond Tutu HIV Foundation (L.-G.B.), University of Cape Town, Cape Town, South Africa; Aeras, Rockville, MD (K.T.R., T.E., R.D.E., B.L., D.A.H., R.H., A.M.G.); Statistical Center for HIV Research, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle (S.G.S.); Sanofi Pasteur, Swiftwater, PA (R.R., S.G., C.A.D.); and Center for Vaccine Research, Statens Serum Institut, Copenhagen (P.A., I.K.).; Hopkins R; From the South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, Department of Pathology (E.N., H.G., V.R., F.R., N.B., S.M., L.M., M.E., A.T., H.M., W.A.H., T.J.S., M.H.), and Desmond Tutu HIV Foundation (L.-G.B.), University of Cape Town, Cape Town, South Africa; Aeras, Rockville, MD (K.T.R., T.E., R.D.E., B.L., D.A.H., R.H., A.M.G.); Statistical Center for HIV Research, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle (S.G.S.); Sanofi Pasteur, Swiftwater, PA (R.R., S.G., C.A.D.); and Center for Vaccine Research, Statens Serum Institut, Copenhagen (P.A., I.K.).; Ginsberg AM; From the South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, Department of Pathology (E.N., H.G., V.R., F.R., N.B., S.M., L.M., M.E., A.T., H.M., W.A.H., T.J.S., M.H.), and Desmond Tutu HIV Foundation (L.-G.B.), University of Cape Town, Cape Town, South Africa; Aeras, Rockville, MD (K.T.R., T.E., R.D.E., B.L., D.A.H., R.H., A.M.G.); Statistical Center for HIV Research, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle (S.G.S.); Sanofi Pasteur, Swiftwater, PA (R.R., S.G., C.A.D.); and Center for Vaccine Research, Statens Serum Institut, Copenhagen (P.A., I.K.).; Scriba TJ; From the South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, Department of Pathology (E.N., H.G., V.R., F.R., N.B., S.M., L.M., M.E., A.T., H.M., W.A.H., T.J.S., M.H.), and Desmond Tutu HIV Foundation (L.-G.B.), University of Cape Town, Cape Town, South Africa; Aeras, Rockville, MD (K.T.R., T.E., R.D.E., B.L., D.A.H., R.H., A.M.G.); Statistical Center for HIV Research, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle (S.G.S.); Sanofi Pasteur, Swiftwater, PA (R.R., S.G., C.A.D.); and Center for Vaccine Research, Statens Serum Institut, Copenhagen (P.A., I.K.).; Hatherill M; From the South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, Department of Pathology (E.N., H.G., V.R., F.R., N.B., S.M., L.M., M.E., A.T., H.M., W.A.H., T.J.S., M.H.), and Desmond Tutu HIV Foundation (L.-G.B.), University of Cape Town, Cape Town, South Africa; Aeras, Rockville, MD (K.T.R., T.E., R.D.E., B.L., D.A.H., R.H., A.M.G.); Statistical Center for HIV Research, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle (S.G.S.); Sanofi Pasteur, Swiftwater, PA (R.R., S.G., C.A.D.); and Center for Vaccine Research, Statens Serum Institut, Copenhagen (P.A., I.K.).
Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print Cited Medium: Internet ISSN: 1533-4406 (Electronic) Linking ISSN: 00284793 NLM ISO Abbreviation: N Engl J Med Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[검색어] Dlakavu, P.
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어